Altamira Therapeutics Ltd. (CYTOF)
OTCMKTS · Delayed Price · Currency is USD
0.0510
0.00 (0.00%)
Sep 5, 2025, 4:00 PM EDT
Altamira Therapeutics Market Cap
Altamira Therapeutics has a market cap or net worth of $293.20 thousand as of September 5, 2025. Its market cap has decreased by -89.93% in one year.
Market Cap
293.20K
Enterprise Value
1.08M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.05
Market Cap Chart
Since August 8, 2014, Altamira Therapeutics's market cap has decreased from 171.70M to 293.20K, a decrease of -99.83%. That is a compound annual growth rate of -43.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2025 | 293.20K | -21.99% |
| Dec 31, 2024 | 375.87K | -72.84% |
| Dec 29, 2023 | 1.38M | -75.59% |
| Dec 30, 2022 | 5.67M | -78.93% |
| Dec 31, 2021 | 26.91M | -10.02% |
| Dec 31, 2020 | 29.91M | 459.11% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 840.66M |
| Elite Pharmaceuticals | 757.64M |
| Tian'an Technology Group | 660.01M |
| Glass House Brands | 561.06M |
| Northwest Biotherapeutics | 393.37M |
| CytoDyn | 391.17M |
| American Oncology Network | 361.55M |